參考文獻(xiàn)

[1] Monticone S, Losano I, Tetti M, et al. Diagnostic approach to low‐renin hypertension[J]. Clinical Endocrinology, 2018, 89(4): 385-396.

[2] Guo, Z, et al. Aldosterone LC-MS/MS Assay-Specific Threshold Values in Screening and Confirmatory Testing for Primary Aldosteronism. The journal of clinical endocrinology and metabolism, 2018, [Online] 103 (11), 3965–3973.

[3] 中華醫(yī)學(xué)會(huì)內(nèi)分泌學(xué)分會(huì). 原發(fā)性醛固酮增多癥的診斷和治療專家共識(shí)（2020年版）[J]. 中華內(nèi)分泌與代謝雜志, 2020, 36(9):727-736.

[4] Carey, William D. & Carey, William D. (William Dahill), Current clinical medicine, 2nd ed.  (Philadelphia: Saunders Elsevier, 2010).

[5] Mayo clinic laboratories. ANGII-Angiotensin II and Angiotensin(1-7), Plasma [EB/OL]. https: // www. mayocliniclabs. com/test-catalog / Overview / 609051, 2020.6.16 / 2021.10.20.

[6] Lo, Clara Wai, et al. Quantitation of plasma angiotensin II in healthy Chinese subjects by a validated liquid chromatography tandem mass spectrometry method, Biomedical chromatography 36:5 , 2022, p. e5318–n/a, doi:10.1002/bmc.5318.

[7] 張志玲, 張火兵, 季明, 等. 不同年齡段中學(xué)生100例高血壓患者血漿腎素活性、血管緊張素Ⅱ、醛固酮水平分析[J]. 標(biāo)記免疫分析與臨床, 2018, 25(6): 772-773.

[8] Van der Gugten JG, Holmes DT. Quantitation of plasma renin activity in plasma using liquid chromatography-tandem mass spectrometry (LC-MS/MS) [J]. Methods Mol Biol, 2016, 1378: 243-253.